- Home
- OPTX vs ANTX Comparison
OPTX vs ANTX Comparison
Compare OPTX & ANTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OPTX
- ANTX
- Stock Information
- Founded
- OPTX 1981
- ANTX 2017
- Country
- OPTX United States
- ANTX United States
- Employees
- OPTX N/A
- ANTX N/A
- Industry
- OPTX Blank Checks
- ANTX Biotechnology: Pharmaceutical Preparations
- Sector
- OPTX Finance
- ANTX Health Care
- Exchange
- OPTX Nasdaq
- ANTX Nasdaq
- Market Cap
- OPTX 40.4M
- ANTX 38.5M
- IPO Year
- OPTX N/A
- ANTX 2022
- Fundamental
- Price
- OPTX $1.43
- ANTX $1.27
- Analyst Decision
- OPTX
- ANTX Buy
- Analyst Count
- OPTX 0
- ANTX 4
- Target Price
- OPTX N/A
- ANTX $3.50
- AVG Volume (30 Days)
- OPTX 146.1K
- ANTX 67.5K
- Earning Date
- OPTX 05-23-2025
- ANTX 05-13-2025
- Dividend Yield
- OPTX N/A
- ANTX N/A
- EPS Growth
- OPTX N/A
- ANTX N/A
- EPS
- OPTX 0.00
- ANTX N/A
- Revenue
- OPTX $29,392,186.00
- ANTX N/A
- Revenue This Year
- OPTX N/A
- ANTX N/A
- Revenue Next Year
- OPTX N/A
- ANTX N/A
- P/E Ratio
- OPTX $858.98
- ANTX N/A
- Revenue Growth
- OPTX 4.36
- ANTX N/A
- 52 Week Low
- OPTX $0.85
- ANTX $0.87
- 52 Week High
- OPTX $8.39
- ANTX $3.07
- Technical
- Relative Strength Index (RSI)
- OPTX 56.30
- ANTX 46.40
- Support Level
- OPTX $1.19
- ANTX $1.18
- Resistance Level
- OPTX $1.72
- ANTX $1.33
- Average True Range (ATR)
- OPTX 0.17
- ANTX 0.08
- MACD
- OPTX 0.04
- ANTX -0.01
- Stochastic Oscillator
- OPTX 58.57
- ANTX 48.15
About OPTX Syntec Optics Holdings Inc.
Syntec Optics Holdings Inc is vertically integrated from design and component manufacturing for lens system assembly to imaging module integration for system solutions. Making its tools, molding, and nano machining allows close interaction and recut ability, enabling special techniques to hold tolerances to sub-micron levels. It has steadily developed a variety of other complementary manufacturing techniques to provide a wide suite of horizontal capabilities including thin film deposition coatings, glass molding, polymer molding, tool-making, mechanical manufacturing, and nano machining.
About ANTX AN2 Therapeutics Inc.
AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology.